Cargando…
DysPIA: A Novel Dysregulated Pathway Identification Analysis Method
Differential co-expression-based pathway analysis is still limited and not widely used. In most current methods, the pathways were considered as gene sets, but the gene regulation relationships were not considered, and the computational speed was slow. In this article, we proposed a novel Dysregulat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287415/ https://www.ncbi.nlm.nih.gov/pubmed/34290733 http://dx.doi.org/10.3389/fgene.2021.647653 |
_version_ | 1783723913574875136 |
---|---|
author | Wang, Limei Xie, Weixin Li, Kongning Wang, Zhenzhen Li, Xia Feng, Weixing Li, Jin |
author_facet | Wang, Limei Xie, Weixin Li, Kongning Wang, Zhenzhen Li, Xia Feng, Weixing Li, Jin |
author_sort | Wang, Limei |
collection | PubMed |
description | Differential co-expression-based pathway analysis is still limited and not widely used. In most current methods, the pathways were considered as gene sets, but the gene regulation relationships were not considered, and the computational speed was slow. In this article, we proposed a novel Dysregulated Pathway Identification Analysis (DysPIA) method to overcome these shortcomings. We adopted the idea of Correlation by Individual Level Product into analysis and performed a fast enrichment analysis. We constructed a combined gene-pair background which was much more sufficient than the background used in Edge Set Enrichment Analysis. In simulation study, DysPIA was able to identify the causal pathways with high AUC (0.9584 to 0.9896). In p53 mutation data, DysPIA obtained better performance than other methods. It obtained more potential dysregulated pathways that could be literature verified, and it ran much faster (∼1,700–8,000 times faster than other methods when 10,000 permutations). DysPIA was also applied to breast cancer relapse dataset and breast cancer subtype dataset. The results show that DysPIA is effective and has a great biological significance. R packages “DysPIA” and “DysPIAData” are constructed and freely available on R CRAN (https://cran.r-project.org/web/packages/DysPIA/index.html and https://cran.r-project.org/web/packages/DysPIAData/index.html), and on GitHub (https://github.com/lemonwang2020). |
format | Online Article Text |
id | pubmed-8287415 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82874152021-07-20 DysPIA: A Novel Dysregulated Pathway Identification Analysis Method Wang, Limei Xie, Weixin Li, Kongning Wang, Zhenzhen Li, Xia Feng, Weixing Li, Jin Front Genet Genetics Differential co-expression-based pathway analysis is still limited and not widely used. In most current methods, the pathways were considered as gene sets, but the gene regulation relationships were not considered, and the computational speed was slow. In this article, we proposed a novel Dysregulated Pathway Identification Analysis (DysPIA) method to overcome these shortcomings. We adopted the idea of Correlation by Individual Level Product into analysis and performed a fast enrichment analysis. We constructed a combined gene-pair background which was much more sufficient than the background used in Edge Set Enrichment Analysis. In simulation study, DysPIA was able to identify the causal pathways with high AUC (0.9584 to 0.9896). In p53 mutation data, DysPIA obtained better performance than other methods. It obtained more potential dysregulated pathways that could be literature verified, and it ran much faster (∼1,700–8,000 times faster than other methods when 10,000 permutations). DysPIA was also applied to breast cancer relapse dataset and breast cancer subtype dataset. The results show that DysPIA is effective and has a great biological significance. R packages “DysPIA” and “DysPIAData” are constructed and freely available on R CRAN (https://cran.r-project.org/web/packages/DysPIA/index.html and https://cran.r-project.org/web/packages/DysPIAData/index.html), and on GitHub (https://github.com/lemonwang2020). Frontiers Media S.A. 2021-07-05 /pmc/articles/PMC8287415/ /pubmed/34290733 http://dx.doi.org/10.3389/fgene.2021.647653 Text en Copyright © 2021 Wang, Xie, Li, Wang, Li, Feng and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Wang, Limei Xie, Weixin Li, Kongning Wang, Zhenzhen Li, Xia Feng, Weixing Li, Jin DysPIA: A Novel Dysregulated Pathway Identification Analysis Method |
title | DysPIA: A Novel Dysregulated Pathway Identification Analysis Method |
title_full | DysPIA: A Novel Dysregulated Pathway Identification Analysis Method |
title_fullStr | DysPIA: A Novel Dysregulated Pathway Identification Analysis Method |
title_full_unstemmed | DysPIA: A Novel Dysregulated Pathway Identification Analysis Method |
title_short | DysPIA: A Novel Dysregulated Pathway Identification Analysis Method |
title_sort | dyspia: a novel dysregulated pathway identification analysis method |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287415/ https://www.ncbi.nlm.nih.gov/pubmed/34290733 http://dx.doi.org/10.3389/fgene.2021.647653 |
work_keys_str_mv | AT wanglimei dyspiaanoveldysregulatedpathwayidentificationanalysismethod AT xieweixin dyspiaanoveldysregulatedpathwayidentificationanalysismethod AT likongning dyspiaanoveldysregulatedpathwayidentificationanalysismethod AT wangzhenzhen dyspiaanoveldysregulatedpathwayidentificationanalysismethod AT lixia dyspiaanoveldysregulatedpathwayidentificationanalysismethod AT fengweixing dyspiaanoveldysregulatedpathwayidentificationanalysismethod AT lijin dyspiaanoveldysregulatedpathwayidentificationanalysismethod |